Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation

Authors: Britt J. P. Hupkens, MD, Monique Maas, MD, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

The watch-and-wait approach after chemoradiation for rectal cancer has gained interest over the past 10 years.1 One of the main prerequisites for a watch-and-wait approach is an accurate selection of patients with a complete response (CR). Studies have shown that a strict selection strategy leads to a low risk for missing residual tumour but up to 30% of complete responders are “missed” and actually do have a CR after surgery.2 Response evaluation is generally performed 8–10 weeks after CRT, while response appears to be ongoing for at least 14 weeks after CRT.3 Also, the clinical images of a responding tumour tend to lag behind compared to the “true response.” By extending the waiting interval with 6–12 weeks, the number of accurately selected CRs is expected to increase. However, one of the main questions was whether patients who achieve a CR after an extended interval have a similar long-term outcome as patients who already have a CR 6–8 weeks after CRT. …
Literature
1.
2.
go back to reference Maas M, Lambregts DM, Nelemans PJ, et al. Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol. 2015;22(12):3873–80.CrossRefPubMedCentralPubMed Maas M, Lambregts DM, Nelemans PJ, et al. Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol. 2015;22(12):3873–80.CrossRefPubMedCentralPubMed
3.
go back to reference Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100(7):933–9.CrossRefPubMed Sloothaak DA, Geijsen DE, van Leersum NJ, et al. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013;100(7):933–9.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Decision Timing for Organ Preservation in Rectal Cancer After Chemoradiation
Authors
Britt J. P. Hupkens, MD
Monique Maas, MD, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-7032-2

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue